Kenvue Inc. $KVUE Stock Holdings Cut by Saturna Capital Corp

Saturna Capital Corp lessened its position in Kenvue Inc. (NYSE:KVUE) by 2.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,676,887 shares of the company’s stock after selling 41,820 shares during the period. Saturna Capital Corp owned approximately 0.09% of Kenvue worth $28,926,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Physician Wealth Advisors Inc. grew its holdings in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after acquiring an additional 618 shares during the period. Elyxium Wealth LLC acquired a new stake in Kenvue in the 4th quarter valued at about $26,000. SBI Securities Co. Ltd. boosted its position in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after purchasing an additional 1,027 shares in the last quarter. Leonteq Securities AG acquired a new position in shares of Kenvue in the 4th quarter worth approximately $45,000. Finally, Hantz Financial Services Inc. grew its stake in shares of Kenvue by 157.2% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,850 shares of the company’s stock worth $46,000 after purchasing an additional 1,742 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on KVUE. UBS Group cut their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Citigroup cut their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Finally, Canaccord Genuity Group boosted their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $19.33.

Insiders Place Their Bets

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.59% of the company’s stock.

Kenvue Stock Up 0.8%

NYSE:KVUE opened at $18.06 on Thursday. The firm has a market capitalization of $34.67 billion, a price-to-earnings ratio of 21.24, a PEG ratio of 1.36 and a beta of 0.54. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The business’s fifty day moving average price is $17.40 and its 200 day moving average price is $17.52.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the company posted $0.24 EPS. On average, sell-side analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. Kenvue’s payout ratio is presently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.